{"database": "lobbying", "table": "lobbying_activities", "rows": [[2869313, "c19ebd7a-203f-4a56-aab0-8b794c28ca5a", "Q3", "KNIGHT CAPITOL CONSULTANTS", 40036301, "REGENXBIO", 2022, "third_quarter", "PHA", "Possible legislation which may affect Food and Drug Administration review of biologic products (no specific bill)", "SENATE", 60000, null, 0, 0, "2022-10-17T17:55:53-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2869313"], "units": {}, "query_ms": 11.52159390039742, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}